Literature DB >> 3188844

Melanotic medulloblastoma. A case report with immunohistochemical and ultrastructural examination.

C L Dolman1.   

Abstract

A melanotic medulloblastoma is reported with electron microscopic and immunohistochemical findings. The cerebellar tumor had seeded through the cerebrospinal fluid to cerebrum and spinal cord, spread through the dura, and metastasized to the lungs. It consisted of (i) anaplastic cells with slight neuronal differentiation, but without the fibrillary background of neuroblastomas, and (ii) epithelial islands pigments with melanin. The latter participated in the spread through the subarachnoid space, but did not extend beyond the dura. Electron microscopy revealed in the pigmented cells tight junctions and oculo-cutaneous melanin, including premelanosomes. The anaplastic cells had undistinguished organelles and only small junctions. On immunohistochemistry, the cytoplasm of the anaplastic cells was positive for neuron-specific enolase and neurofilament, and some of the nuclei were positive to S-100, confirming neuronal differentiation. The cells did not stain for glial fibrillary acidic protein, carcinoembryonic antigen, cytokeratin, alpha fetoprotein, vimentin, and epithelial membrane antigen. The melanotic cells were negative to all reagents tested, even to S-100 protein. The presence of oculo-cutaneous melanin and of neuronal elements indicate a neuroectodermal or neural crest origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3188844     DOI: 10.1007/bf00686394

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  A malignant melanin-forming tumour of the cerebellum.

Authors:  M FOWLER; D A SIMPSON
Journal:  J Pathol Bacteriol       Date:  1962-10

Review 2.  Central neural antigens: detection and diagnostic application.

Authors:  A Borit; T E Brooks; N G Ordóñez; B A Kakulas
Journal:  Crit Rev Clin Lab Sci       Date:  1986       Impact factor: 6.250

3.  Melanotic medulloblastoma of the cerebellum.

Authors:  J H Sung; A R Mastri; E L Segal
Journal:  J Neuropathol Exp Neurol       Date:  1973-07       Impact factor: 3.685

4.  A medulloblastoma-like tumour with melanin formation.

Authors:  P V Best
Journal:  J Pathol       Date:  1973-05       Impact factor: 7.996

5.  Melanin as a component of cerebral gliomas: the melanotic cerebral ependymoma.

Authors:  J J McCloskey; J C Parker; W H Brooks; H M Blacker
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

Review 6.  Malignant melanotic neuroectodermal tumor of infancy: a clinical, pathologic, ultrastructural and tissue culture study.

Authors:  L P Dehner; R K Sibley; J J Sauk; R A Vickers; M E Nesbit; A S Leonard; D E Waite; J E Neeley; J Ophoven
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

7.  Melanotic neuroectodermal tumors of the brain and skull.

Authors:  J F Hahn; E E Sperber; M G Netsky
Journal:  J Neuropathol Exp Neurol       Date:  1976 Sep-Oct       Impact factor: 3.685

8.  A pigmented differentiating neuroblastoma: a light and ultrastructural study.

Authors:  J D Mullins
Journal:  Cancer       Date:  1980-08-01       Impact factor: 6.860

Review 9.  Immunohistochemistry of central nervous system tumors. Its contributions to neurosurgical diagnosis.

Authors:  J M Bonnin; L J Rubinstein
Journal:  J Neurosurg       Date:  1984-06       Impact factor: 5.115

10.  Melanotic neuroectodermal tumor of infancy: its histological similarities to fetal pineal gland.

Authors:  E C Dooling; J G Chi; F H Gilles
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

View more
  9 in total

1.  Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.

Authors:  Alexandros D Polydorides; Arie Perry; Mark A Edgar
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

2.  Immunohistochemistry of primitive neuroectodermal tumors in infants with special emphasis on cytokeratin expression.

Authors:  T Grieshammer; C Zimmer; K T Vogeley
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 3.  Melanotic medulloblastoma in children.

Authors:  Wen-yan Li; Lu Ma; Jian Liu; Hua Yang; Qing Mao
Journal:  Childs Nerv Syst       Date:  2011-01-26       Impact factor: 1.475

Review 4.  Medulloblastoma with melanotic differentiation: case report and review of the literature.

Authors:  Christine L Phillips; Lili Miles; Blaise V Jones; Mary Sutton; Kerry Crone; Maryam Fouladi
Journal:  J Neurooncol       Date:  2010-10-16       Impact factor: 4.130

5.  Melanotic cerebral ganglioglioma: evidence for melanogenesis in neoplastic astrocytes.

Authors:  D Soffer; B Lach; S Constantini
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Medullomyoblastoma: report of two cases.

Authors:  D Schiffer; M T Giordana; S Pezzotta; T Pezzulo; M C Vigliani
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

7.  Neuropathology of neurocutaneous melanosis: histological foci of melanotic neurones and glia may be undetectable on MRI.

Authors:  Veronica A Kinsler; Simon M L Paine; Glenn W Anderson; D Saraji Wijesekara; Neil J Sebire; Wui K Chong; William Harkness; Sarah E Aylett; Thomas S Jacques
Journal:  Acta Neuropathol       Date:  2012-03       Impact factor: 17.088

8.  Melanotic Neuroectodermal Tumor of Infancy (MNTI) and Pineal Anlage Tumor (PAT) Harbor A Medulloblastoma Signature by DNA Methylation Profiling.

Authors:  Oscar Lopez-Nunez; Rita Alaggio; Ivy John; Andrea Ciolfi; Lucia Pedace; Angela Mastronuzzi; Francesca Gianno; Felice Giangaspero; Sabrina Rossi; Vittoria Donofrio; Giuseppe Cinalli; Lea F Surrey; Marco Tartaglia; Franco Locatelli; Evelina Miele
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.